Home » Ambit, Bristol Myers-Squibb Expand Kinase Screening Pact

Ambit, Bristol Myers-Squibb Expand Kinase Screening Pact

Oct 31, 2007
NEW YORK (GenomeWeb News) - Ambit Biosciences has expanded an agreement with Bristol-Myers Squibb for kinase discovery research, Ambit said today.
 
Under the agreement, Ambit will use its KinomeScan method to screen small-molecule libraries against "a large number of human kinases," Ambit said, continuing a relationship begun in 2004.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.